Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer

Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer

Guardado en:
Detalles Bibliográficos
Autores principales: Alessio Bruni, Vieri Scotti, Paolo Borghetti, Stefano Vagge, Salvatore Cozzi, Elisa D’Angelo, Niccolò Giaj Levra, Alessandra Fozza, Maria Taraborrelli, Gaia Piperno, Valentina Vanoni, Matteo Sepulcri, Marco Trovò, Valerio Nardone, Elisabetta Lattanzi, Said Bou Selman, Federica Bertolini, Davide Franceschini, Francesco Agustoni, Barbara Alicja Jereczek-Fossa, Stefano Maria Magrini, Lorenzo Livi, Frank Lohr, Andrea Riccardo Filippi
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
chemoradiotherapy
immunotherapy
stage III
unresectable
NSCLC
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/0768392c0cb64c4c83ee24c74494057f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0768392c0cb64c4c83ee24c74494057f
record_format dspace
spelling oai:doaj.org-article:0768392c0cb64c4c83ee24c74494057f2021-11-16T08:00:59ZCorrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer2234-943X10.3389/fonc.2021.802949https://doaj.org/article/0768392c0cb64c4c83ee24c74494057f2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.802949/fullhttps://doaj.org/toc/2234-943XAlessio BruniVieri ScottiPaolo BorghettiStefano VaggeSalvatore CozziElisa D’AngeloNiccolò Giaj LevraAlessandra FozzaMaria TaraborrelliGaia PipernoValentina VanoniMatteo SepulcriMarco TrovòValerio NardoneElisabetta LattanziSaid Bou SelmanFederica BertoliniDavide FranceschiniFrancesco AgustoniBarbara Alicja Jereczek-FossaBarbara Alicja Jereczek-FossaStefano Maria MagriniLorenzo LiviFrank LohrAndrea Riccardo FilippiFrontiers Media S.A.articlechemoradiotherapyimmunotherapystage IIIunresectableNSCLCNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic chemoradiotherapy
immunotherapy
stage III
unresectable
NSCLC
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle chemoradiotherapy
immunotherapy
stage III
unresectable
NSCLC
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Alessio Bruni
Vieri Scotti
Paolo Borghetti
Stefano Vagge
Salvatore Cozzi
Elisa D’Angelo
Niccolò Giaj Levra
Alessandra Fozza
Maria Taraborrelli
Gaia Piperno
Valentina Vanoni
Matteo Sepulcri
Marco Trovò
Valerio Nardone
Elisabetta Lattanzi
Said Bou Selman
Federica Bertolini
Davide Franceschini
Francesco Agustoni
Barbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa
Stefano Maria Magrini
Lorenzo Livi
Frank Lohr
Andrea Riccardo Filippi
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
format article
author Alessio Bruni
Vieri Scotti
Paolo Borghetti
Stefano Vagge
Salvatore Cozzi
Elisa D’Angelo
Niccolò Giaj Levra
Alessandra Fozza
Maria Taraborrelli
Gaia Piperno
Valentina Vanoni
Matteo Sepulcri
Marco Trovò
Valerio Nardone
Elisabetta Lattanzi
Said Bou Selman
Federica Bertolini
Davide Franceschini
Francesco Agustoni
Barbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa
Stefano Maria Magrini
Lorenzo Livi
Frank Lohr
Andrea Riccardo Filippi
author_facet Alessio Bruni
Vieri Scotti
Paolo Borghetti
Stefano Vagge
Salvatore Cozzi
Elisa D’Angelo
Niccolò Giaj Levra
Alessandra Fozza
Maria Taraborrelli
Gaia Piperno
Valentina Vanoni
Matteo Sepulcri
Marco Trovò
Valerio Nardone
Elisabetta Lattanzi
Said Bou Selman
Federica Bertolini
Davide Franceschini
Francesco Agustoni
Barbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa
Stefano Maria Magrini
Lorenzo Livi
Frank Lohr
Andrea Riccardo Filippi
author_sort Alessio Bruni
title Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
title_short Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
title_full Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
title_fullStr Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
title_full_unstemmed Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
title_sort corrigendum: a real-world, multicenter, observational retrospective study of durvalumab after concomitant or sequential chemoradiation for unresectable stage iii non-small cell lung cancer
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/0768392c0cb64c4c83ee24c74494057f
work_keys_str_mv AT alessiobruni corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT vieriscotti corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT paoloborghetti corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT stefanovagge corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT salvatorecozzi corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT elisadangelo corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT niccologiajlevra corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT alessandrafozza corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT mariataraborrelli corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT gaiapiperno corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT valentinavanoni corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT matteosepulcri corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT marcotrovo corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT valerionardone corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT elisabettalattanzi corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT saidbouselman corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT federicabertolini corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT davidefranceschini corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT francescoagustoni corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT barbaraalicjajereczekfossa corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT barbaraalicjajereczekfossa corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT stefanomariamagrini corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT lorenzolivi corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT franklohr corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
AT andreariccardofilippi corrigendumarealworldmulticenterobservationalretrospectivestudyofdurvalumabafterconcomitantorsequentialchemoradiationforunresectablestageiiinonsmallcelllungcancer
_version_ 1718426584959942656

Ejemplares similares